VVTMF (VVT Med) Short-Term Debt: $0.63 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VVT Med Short-Term Debt?

VVT Med VVTMF Short-Term Debt is $0.63 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

VVT Med's Short-Term Debt for the quarter that ended in Mar. 2026 was $0.63 Mil.

VVT Med's quarterly Short-Term Debt increased from Sep. 2025 ($0.36 Mil) to Dec. 2025 ($0.60 Mil) and increased from Dec. 2025 ($0.60 Mil) to Mar. 2026 ($0.63 Mil).

VVT Med's annual Short-Term Debt increased from Dec. 2023 ($3.37 Mil) to Dec. 2024 ($5.50 Mil) but then declined from Dec. 2024 ($5.50 Mil) to Dec. 2025 ($0.60 Mil).

VVT Med Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

VVT Med Short-Term Debt Related Terms

VVT Med Short-Term Debt Historical Data

* Premium members only.

The historical data trend for VVT Med's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med Short-Term Debt Chart

VVT Med Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Short-Term Debt
2.49 3.37 5.50 0.60

VVT Med Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.85 3.74 0.36 0.60 0.63
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.63 Mil mean?
VVT Med (VVTMF) has a Short-Term Debt of $0.63 Mil as of Mar. 2026.
Is VVT Med's Short-Term Debt too high?
VVT Med's current Short-Term Debt is $0.63 Mil.
How does VVT Med's Short-Term Debt compare to ABT and SYK?
VVT Med's Short-Term Debt of $0.63 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. VVT Med's current Short-Term Debt is $0.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current Short-Term Debt of $0.63 Mil. The current Short-Term Debt is $0.63 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For VVT Med (VVTMF), the current Short-Term Debt is $0.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.